查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
肌少症治療市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按治療類型、配銷通路和地理位置
市場調查報告書
商品編碼
1408645

肌少症治療市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按治療類型、配銷通路和地理位置

Sarcopenia Treatment Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment Type, Distribution Channel, and Geography
出版日期: | 出版商: The Insight Partners | 英文 134 Pages | 訂單完成後即時交付

價格

根據我們最新的《肌少症治療市場預測至 2030 年 - 全球分析 - 治療類型和配銷通路》研究顯示，肌少症治療市場價值預計將從2022 年的33.97 億美元增至2030 年的52.64 億美元。該報告重點介紹了市場的普遍趨勢以及推動和阻礙肌肉減少症治療市場成長的因素。

人們對肌少症及其對健康的負面影響的認知不斷增強，為醫療保健和老年護理領域的進步提供了廣闊的空間。許多計劃團體和組織正在積極採取措施，提高群眾對肌少症的認知。這些組織經常與醫療專業人員合作，讓公眾了解致病性、目標患者、預防和治療等各個方面的最新資訊，並強調及時診斷和治療的價值。美國衛生與公共服務部婦女健康辦公室（OWH）於2023年發起了「強於肌少症」的全國運動，以提高女性對肌肉減少症的認知。健康與公眾服務部的研究表明，美國超過 45% 的老年人患有肌肉減少症，數百萬年輕人在以後的生活中面臨這種疾病的風險。根據 OWH 的「強於肌少症」運動，敦促女性與醫療保健提供者討論肌少症，然後接受疾病篩檢，並在需要時採取適當的治療。

肌少症已被涵蓋醫學院的課程和針對醫生、護士和物理治療師等醫療保健專業人員的培訓計劃。例如，OWH 與 Medscape Education 合作，為醫療保健專業人員創建繼續醫學教育 (CME) 學分，這將使他們能夠更好地檢測和治療患者的肌肉減少症。主流媒體已擴大對肌少症的報導，包括文章、新聞報導和紀錄片。根據 2022 年 2 月 PubMed 的一篇文章，美國衛生與公眾服務部是美國最大的資助機構之一，贊助了 1,604 項有關肌少症的研究。從 2022 年起，7 月 4 日將被定為世界少肌症日。因此，人們對肌少症認知的提高可能會在未來幾年為肌少症治療市場帶來新的成長趨勢。

肌少症治療市場按治療類型分為維生素 D 和鈣補充劑、蛋白質補充劑、維生素 B12 補充劑等。維生素 D 和鈣補充劑細分市場在 2022 年佔據最大市場佔有率。該細分市場的肌肉減少症治療市場預計 2022 年至 2030 年複合年成長率將達到 6.5% 的最高CAGR。作為一種脂溶性維生素，維生素D 至關重要用於維持鈣穩態和健康的骨骼代謝。補充維生素 D 已被研究為降低肌少症風險的有用飲食策略。維生素 D 水平欠佳的老年人極易患肌肉減少症，通常與跌倒、住院和其他不良反應有關。

加拿大公共衛生局、美國衛生與公眾服務部和美國國立衛生研究院是在準備肌少症治療市場報告時提到的幾個關鍵的主要和次要來源。

目錄

第 1 章：簡介

  • Insight Partners 研究報告指南
  • 市場區隔

第 2 章：執行摘要

  • 重要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：肌少症治療市場格局

  • 概述
  • PEST分析

第 5 章：肌少症治療市場 - 主要產業動態

  • 肌少症治療市場 - 主要產業動態
  • 市場促進因素
    • 老年人口激增
    • 成人營養不良和維生素缺乏症增加
  • 主要市場限制：
    • 無法直接干預
  • 主要市場機會：
    • 處於臨床試驗階段的產品
  • 未來的趨勢：
    • 人們對肌少症的認知不斷提高
  • 促進因素和限制的影響：

第 6 章：肌少症治療市場 - 全球市場分析

  • 肌少症治療市場收入，2022 - 2030
  • 肌少症治療市場預測與分析

第 7 章：肌少症治療市場分析 - 依治療類型

  • 維生素 D 和鈣補充劑
  • 蛋白質補充劑
  • 維生素 B12 補充劑
  • 其他

第 8 章：肌少症治療市場分析 - 按配銷通路

  • 藥局
  • 零售通路
  • 線上通路
  • 其他

第 9 章：肌少症治療市場 - 地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 亞太地區其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第 10 章：肌少症治療市場-產業格局

  • 概述
  • 肌少症治療市場的成長策略
  • 無機成長策略
    • 概述
  • 有機成長策略
    • 概述

第 11 章：公司簡介

  • Abbott Laboratories
  • Bayer AG
  • Metagenics LLC
  • Nestle Health Science SA
  • Novartis AG
  • Pfizer Inc
  • Sanofi SA
  • Amway Corp
  • GSK Plc
  • Makers Nutrition LLC

第 12 章：附錄

  • 關於 Insight Partners
  • 專業術語
Product Code: TIPRE00010491

According to our latest study on "Sarcopenia Treatment Market Forecast to 2030 - Global Analysis - Treatment Type, and Distribution Channel," the sarcopenia treatment market value is expected to reach US$ 5.264 billion by 2030 from US$ 3.397 billion in 2022. The report highlights trends prevailing in the market and factors driving and hindering the growth of the sarcopenia treatment market.

The growing awareness of sarcopenia and its negative impact on health presents a significant scope for advancements in the fields of healthcare and geriatric care. Many advocacy groups and organizations are proactively taking steps to raise the awareness of sarcopenia among the masses. These organizations often work with medical professionals to keep the public updated on the various aspects of pathogenicity, target patients, prevention, and treatments, among other aspects, along with underlining the value of prompt diagnosis and treatment. The Office on Women's Health (OWH) of the US Department of Health and Human Services launched the national campaign "Stronger than Sarcopenia" in 2023 to magnify the awareness of sarcopenia in women. Research by Health and Human Services shows that more than 45% of the elderly population in the US suffers from sarcopenia, and millions of younger individuals are at risk of developing this condition later in their lives. In line with OWH's "Stronger than Sarcopenia" campaign, women are urged to discuss sarcopenia with their healthcare providers, followed by undergoing screen for the illness and taking appropriate therapy if required.

Sarcopenia has been included in the curricula of medical schools and training programs for healthcare professionals such as physicians, nurses, and physical therapists. For example, the OWH worked with Medscape Education to create continuing medical education (CME) credits for healthcare professionals, which will better equip them to detect and treat sarcopenia in their patients. Mainstream media has expanded its coverage of sarcopenia to include articles, news stories, and documentaries. According to a February 2022 PubMed article, the US Department of Health and Human Services is one of the top funding agencies in the US, sponsoring 1,604 studies on sarcopenia. From 2022, July 4 will be observed as World Sarcopenia Day. Thus, the elevating awareness regarding sarcopenia is likely to bring new growth trends into the sarcopenia treatment market in the coming years.

The sarcopenia treatment market, by treatment type, is segmented into vitamin D and calcium supplements, protein supplements, vitamin B12 supplements, and others. The vitamin D and calcium supplements segment held the largest share of the market in 2022. The sarcopenia treatment market for this segment is anticipated to record the highest CAGR of 6.5% from 2022 to 2030. Being a fat-soluble vitamin, vitamin D is crucial for maintaining calcium homeostasis and healthy bone metabolism. The supplementation of vitamin D has been studied as a useful dietary strategy to reduce the risk of sarcopenia. Older adults with suboptimal vitamin D levels are highly susceptible to sarcopenia, often associated with falls, hospitalization, and other adverse effects.

The Public Health Agency of Canada, the US Department of Health and Human Services, and NIH are a few key primary and secondary sources referred to while preparing the report on the sarcopenia treatment market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the sarcopenia treatment market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global sarcopenia treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global sarcopenia treatment market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Sarcopenia Treatment Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Sarcopenia Treatment Market - Key Industry Dynamics

  • 5.1 Sarcopenia Treatment Market - Key Industry Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Upsurge in Geriatric Population
    • 5.2.2 Rise in Malnutrition and Vitamin Deficiency Among Adults
  • 5.3 Key Market Restraints:
    • 5.3.1 Unavailability of Direct Interventions
  • 5.4 Key Market Opportunities:
    • 5.4.1 Products in Clinical Trial Phases
  • 5.5 Future Trends:
    • 5.5.1 Rising Awareness About Sarcopenia
  • 5.6 Impact of Drivers and Restraints:

6. Sarcopenia Treatment Market - Global Market Analysis

  • 6.1 Sarcopenia Treatment Market Revenue (US$ Million), 2022 - 2030
  • 6.2 Sarcopenia Treatment Market Forecast and Analysis

7. Sarcopenia Treatment Market Analysis - By Treatment Type

  • 7.1 Vitamin D and Calcium Supplement
    • 7.1.1 Overview
    • 7.1.2 Vitamin D and Calcium Supplement Market, Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Protein Supplement
    • 7.2.1 Overview
    • 7.2.2 Protein Supplement Market, Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Vitamin B12 Supplement
    • 7.3.1 Overview
    • 7.3.2 Vitamin B12 Supplement Market, Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Others
    • 7.4.1 Overview
    • 7.4.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

8. Sarcopenia Treatment Market Analysis - By Distribution Channel

  • 8.1 Pharmacies
    • 8.1.1 Overview
    • 8.1.2 Pharmacies Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.2 Retail Channels
    • 8.2.1 Overview
    • 8.2.2 Retail Channels Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Online Channels
    • 8.3.1 Overview
    • 8.3.2 Online Channels Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Others
    • 8.4.1 Overview
    • 8.4.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

9. Sarcopenia Treatment Market - Geographical Analysis

  • 9.1 Overview
  • 9.2 North America
    • 9.2.1 North America Sarcopenia Treatment Market Overview
    • 9.2.2 North America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    • 9.2.3 North America Sarcopenia Treatment Market Breakdown by Treatment Type
      • 9.2.3.1 North America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Treatment Type
    • 9.2.4 North America Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.2.4.1 North America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Distribution Channel
    • 9.2.5 North America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
      • 9.2.5.1 North America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
      • 9.2.5.2 United States Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.2.5.2.1 United States Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.2.5.2.2 United States Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.2.5.3 Canada Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.2.5.3.1 Canada Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.2.5.3.2 Canada Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.2.5.4 Mexico Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.2.5.4.1 Mexico Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.2.5.4.2 Mexico Sarcopenia Treatment Market Breakdown by Distribution Channel
  • 9.3 Europe
    • 9.3.1 Europe Sarcopenia Treatment Market Overview
    • 9.3.2 Europe Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    • 9.3.3 Europe Sarcopenia Treatment Market Breakdown by Treatment Type
      • 9.3.3.1 Europe Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Treatment Type
    • 9.3.4 Europe Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.3.4.1 Europe Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Distribution Channel
    • 9.3.5 Europe Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
      • 9.3.5.1 Europe Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
      • 9.3.5.2 Germany Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.3.5.2.1 Germany Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.3.5.2.2 Germany Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.3.5.3 France Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.3.5.3.1 France Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.3.5.3.2 France Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.3.5.4 United Kingdom Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.3.5.4.1 United Kingdom Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.3.5.4.2 United Kingdom Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.3.5.5 Italy Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.3.5.5.1 Italy Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.3.5.5.2 Italy Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.3.5.6 Spain Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.3.5.6.1 Spain Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.3.5.6.2 Spain Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.3.5.7 Rest of Europe Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.3.5.7.1 Rest of Europe Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.3.5.7.2 Rest of Europe Sarcopenia Treatment Market Breakdown by Distribution Channel
  • 9.4 Asia Pacific
    • 9.4.1 Asia Pacific Sarcopenia Treatment Market Overview
    • 9.4.2 Asia Pacific Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    • 9.4.3 Asia Pacific Sarcopenia Treatment Market Breakdown by Treatment Type
      • 9.4.3.1 Asia Pacific Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Treatment Type
    • 9.4.4 Asia Pacific Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.4.4.1 Asia Pacific Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Distribution Channel
    • 9.4.5 Asia Pacific Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
      • 9.4.5.1 Asia Pacific Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
      • 9.4.5.2 China Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.4.5.2.1 China Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.4.5.2.2 China Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.4.5.3 India Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.4.5.3.1 India Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.4.5.3.2 India Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.4.5.4 Japan Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.4.5.4.1 Japan Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.4.5.4.2 Japan Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.4.5.5 South Korea Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.4.5.5.1 South Korea Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.4.5.5.2 South Korea Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.4.5.6 Australia Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.4.5.6.1 Australia Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.4.5.6.2 Australia Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.4.5.7 Rest of APAC Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.4.5.7.1 Rest of APAC Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.4.5.7.2 Rest of APAC Sarcopenia Treatment Market Breakdown by Distribution Channel
  • 9.5 Middle East and Africa
    • 9.5.1 Middle East and Africa Sarcopenia Treatment Market Overview
    • 9.5.2 Middle East and Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    • 9.5.3 Middle East and Africa Sarcopenia Treatment Market Breakdown by Treatment Type
      • 9.5.3.1 Middle East and Africa Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Treatment Type
    • 9.5.4 Middle East and Africa Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.5.4.1 Middle East and Africa Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Distribution Channel
    • 9.5.5 Middle East and Africa Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
      • 9.5.5.1 Middle East and Africa Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
      • 9.5.5.2 South Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.5.5.2.1 South Africa Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.5.5.2.2 South Africa Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.5.5.3 Saudi Arabia Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.5.5.3.1 Saudi Arabia Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.5.5.3.2 Saudi Arabia Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.5.5.4 United Arab Emirates Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.5.5.4.1 United Arab Emirates Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.5.5.4.2 United Arab Emirates Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.5.5.5 Rest of Middle East and Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.5.5.5.1 Rest of Middle East and Africa Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.5.5.5.2 Rest of Middle East and Africa Sarcopenia Treatment Market Breakdown by Distribution Channel
  • 9.6 South and Central America
    • 9.6.1 South and Central America Sarcopenia Treatment Market Overview
    • 9.6.2 South and Central America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    • 9.6.3 South and Central America Sarcopenia Treatment Market Breakdown by Treatment Type
      • 9.6.3.1 South and Central America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Treatment Type
    • 9.6.4 South and Central America Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.6.4.1 South and Central America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Distribution Channel
    • 9.6.5 South and Central America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
      • 9.6.5.1 South and Central America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
      • 9.6.5.2 Brazil Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.6.5.2.1 Brazil Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.6.5.2.2 Brazil Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.6.5.3 Argentina Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.6.5.3.1 Argentina Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.6.5.3.2 Argentina Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 9.6.5.4 Rest of South and Central America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.6.5.4.1 Rest of South and Central America Sarcopenia Treatment Market Breakdown by Treatment Type
        • 9.6.5.4.2 Rest of South and Central America Sarcopenia Treatment Market Breakdown by Distribution Channel

10. Sarcopenia Treatment Market-Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in the Sarcopenia Treatment Market
  • 10.3 Inorganic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Organic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Abbott Laboratories
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Bayer AG
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Metagenics LLC
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Nestle Health Science SA
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Novartis AG
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Pfizer Inc
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Sanofi SA
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Amway Corp
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 GSK Plc
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 Makers Nutrition LLC
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Products and Services
    • 11.10.4 Financial Overview
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary of Terms

List Of Tables

  • Table 1. Sarcopenia Treatment Market Segmentation
  • Table 2. Sarcopenia Drug Under Clinical Development
  • Table 3. Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million)
  • Table 4. Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Treatment Type
  • Table 5. Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Distribution Channel
  • Table 6. North America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 7. North America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 8. North America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Country
  • Table 9. United States Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 10. United States Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 11. Canada Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 12. Canada Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 13. Mexico Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 14. Mexico Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 15. Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 16. Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 17. Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Country
  • Table 18. Germany Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 19. Germany Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 20. France Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 21. France Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 22. United Kingdom Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 23. United Kingdom Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 24. Italy Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 25. Italy Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 26. Spain Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 27. Spain Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 28. Rest of Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 29. Rest of Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 30. Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 31. Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 32. Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Country
  • Table 33. China Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 34. China Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 35. India Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 36. India Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 37. Japan Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 38. Japan Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 39. South Korea Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 40. South Korea Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 41. Australia Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 42. Australia Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 43. Rest of APAC Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 44. Rest of APAC Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 45. Middle East and Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 46. Middle East and Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 47. Middle East and Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Country
  • Table 48. South Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 49. South Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 50. Saudi Arabia Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 51. Saudi Arabia Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 52. United Arab Emirates Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 53. United Arab Emirates Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 54. Rest of Middle East and Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 55. Rest of Middle East and Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 56. South and Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 57. South and Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 58. South and Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Country
  • Table 59. Brazil Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 60. Brazil Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 61. Argentina Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 62. Argentina Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 63. Rest of South and Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
  • Table 64. Rest of South and Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
  • Table 65. Recent Inorganic Growth Strategies in the Sarcopenia Treatment Market
  • Table 66. Recent Organic Growth Strategies in the Sarcopenia Treatment Market
  • Table 67. Glossary of Terms, Sarcopenia Treatment Market

List Of Figures

  • Figure 1. Sarcopenia Treatment Market Segmentation, By Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Sarcopenia Treatment Market Breakdown by Geography, 2022 and 2030 (%)
  • Figure 5. Sarcopenia Treatment Market Revenue (US$ Million), 2022 - 2030
  • Figure 6. Sarcopenia Treatment Market Share (%) - By Treatment Type, 2022 and 2030
  • Figure 7. Vitamin D and Calcium Supplement Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 8. Protein Supplement Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 9. Vitamin B12 Supplement Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 10. Others Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 11. Sarcopenia Treatment Market Share (%) - By Distribution Channel, 2022 and 2030
  • Figure 12. Pharmacies Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 13. Retail Channels Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 14. Online Channels Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 15. Others Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 16. Sarcopenia Treatment Market Breakdown by Region, 2022 and 2030 (%)
  • Figure 17. North America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 18. North America Sarcopenia Treatment Market Breakdown by Treatment Type (2022 and 2030)
  • Figure 19. North America Sarcopenia Treatment Market Breakdown by Distribution Channel (2022 and 2030)
  • Figure 20. North America Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)
  • Figure 21. United States Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 22. Canada Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 23. Mexico Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 24. Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 25. Europe Sarcopenia Treatment Market Breakdown by Treatment Type (2022 and 2030)
  • Figure 26. Europe Sarcopenia Treatment Market Breakdown by Distribution Channel (2022 and 2030)
  • Figure 27. Europe Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)
  • Figure 28. Germany Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 29. France Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 30. United Kingdom Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 31. Italy Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 32. Spain Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 33. Rest of Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 34. Asia Pacific Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 35. Asia Pacific Sarcopenia Treatment Market Breakdown by Treatment Type (2022 and 2030)
  • Figure 36. Asia Pacific Sarcopenia Treatment Market Breakdown by Distribution Channel (2022 and 2030)
  • Figure 37. Asia Pacific Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)
  • Figure 38. China Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 39. India Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 40. Japan Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 41. South Korea Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 42. Australia Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 43. Rest of APAC Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 44. Middle East and Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 45. Middle East and Africa Sarcopenia Treatment Market Breakdown by Treatment Type (2022 and 2030)
  • Figure 46. Middle East and Africa Sarcopenia Treatment Market Breakdown by Distribution Channel (2022 and 2030)
  • Figure 47. Middle East and Africa Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)
  • Figure 48. South Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 49. Saudi Arabia Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 50. United Arab Emirates Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 51. Rest of Middle East and Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 52. South and Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 53. South and Central America Sarcopenia Treatment Market Breakdown by Treatment Type (2022 and 2030)
  • Figure 54. South and Central America Sarcopenia Treatment Market Breakdown by Distribution Channel (2022 and 2030)
  • Figure 55. South and Central America Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)
  • Figure 56. Brazil Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 57. Argentina Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 58. Rest of South and Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 59. Growth Strategies in the Sarcopenia Treatment Market